SS
PRQR icon

SBI Securities’s ProQR Therapeutics PRQR Stock Holding History

SBI Securities’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$958 Hold
515
– – ﹤0.01% 2822
2026
Q1 		$834 Hold
515
– – ﹤0.01% 2723
2025
Q4 		$1.04K Sell
515
-37
-7% -$86 ﹤0.01% 2632
2025
Q3 		$1.18K Sell
552
-6
-1% -$13 ﹤0.01% 2631
2025
Q2 		$1.14K Hold
558
– – ﹤0.01% 2625
2025
Q1 		$742 Buy
558
+460
+469% +$979 ﹤0.01% 2715
2024
Q4 		$260 Buy
+98
New +$311 ﹤0.01% 3149

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

SBI Securities's PRQR Position: Q2 2026 in Review

SBI Securities held its ProQR Therapeutics (PRQR) position steady in Q2 2026 at 515 shares worth $958. The position accounts for ﹤0.01% of the portfolio, ranked #2822.

SBI Securities first reported a position in PRQR in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.18K in Q3 2025. 70 funds tracked by Wall St. Rank hold PRQR as of Q2 2026.

  • SBI Securities held 515 shares of ProQR Therapeutics worth $958 as of Q2 2026.
  • SBI Securities left its ProQR Therapeutics share count unchanged in Q2 2026.
  • ProQR Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2822 holding.
  • SBI Securities first reported a position in ProQR Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's ProQR Therapeutics position peaked at $1.18K in Q3 2025.
  • 70 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.